
π#HealthTech + #HealthSpan π πhttps://nitter.cf/t.co/AvL0tY6Vnr @BodyMapDigital π Dyslexic Entrepreneur π¦Έπ½ββοΈπ©π½βπ¬π ππΌββοΈ π΄ββοΈ ππΌββοΈπ§π½ββοΈπ§πΎβ #TimeTraveler
- Tweets9.9K
- Following1.4K
- Followers1.4K
- Likes16.6K

ALT Glucagon-like peptideβ1 (GLP-1) receptor agonists are among the most effective treatments for obesity and other metabolic disorders. With widespread use of these drugs, it has become clear that their effects go well beyond health conditions traditionally linked to metabolism, affecting multiple other organ systems, particularly the brain. Continued research in this field has also expanded beyond the GLP-1 receptor as a target, with the development of additional drugs and combinations to help optimize patient care. Illustration: C. Bickel/Science

ALT Ref - https://www.nature.com/articles/s41574-025-01195-9 - "Neurodegeneration is not merely determined by local cues but is also influenced by systemic signals, such as factors released by peripheral tissues. Muscle-to-brain communication via muscle-secreted signalling factors is increasingly recognized as an important signalling axis. Collectively, muscle-to-brain signalling could be harnessed to impede neurodegeneration and delay cognitive decline during ageing."















